{"pmid":32323581,"title":"The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience.","text":["The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience.","Future Oncol","Kattan, Clarisse","Badreddine, Hassan","Rassy, Elie","Kourie, Hampig Raphael","Kattan, Joseph","32323581"],"journal":"Future Oncol","authors":["Kattan, Clarisse","Badreddine, Hassan","Rassy, Elie","Kourie, Hampig Raphael","Kattan, Joseph"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323581","week":"202017|Apr 20 - Apr 26","doi":"10.2217/fon-2020-0313","keywords":["covid-19","lebanon","cancer patients","coronavirus","middle-income"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Lebanon"],"countries":["Lebanon"],"countries_codes":["LBN|Lebanon"],"_version_":1664895932830842880,"score":8.518259,"similar":[{"pmid":32266838,"pmcid":"PMC7142391","title":"The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic.","text":["The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic.","Future Oncol","Bitar, Nizar","Kattan, Joseph","Kourie, Hampig Raphael","Mukherji, Deborah","Saghir, Nagi El","32266838"],"journal":"Future Oncol","authors":["Bitar, Nizar","Kattan, Joseph","Kourie, Hampig Raphael","Mukherji, Deborah","Saghir, Nagi El"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266838","week":"202015|Apr 06 - Apr 12","doi":"10.2217/fon-2020-0252","keywords":["covid-19","cancer patients","lebanon","oncology staff","recommendations"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664637636059332608,"score":106.10365},{"pmid":32333196,"title":"Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak.","text":["Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak.","As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined that the incidence of lymphopenia increased in COVID-19 and there was a significant relationship between lymphopenia and mortality. This can be thought of as an unresponsive problem in how to maintain anti-cancer drugs that cause lymphopenia. This article was written for a hypothetical approach in cancer patients diagnosed with COVID-19 in order to be an idea of collecting data for treatment with anti-cancer drugs that cause lymphopenia.","Med Oncol","Tanriverdi, Ozgur","32333196"],"abstract":["As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined that the incidence of lymphopenia increased in COVID-19 and there was a significant relationship between lymphopenia and mortality. This can be thought of as an unresponsive problem in how to maintain anti-cancer drugs that cause lymphopenia. This article was written for a hypothetical approach in cancer patients diagnosed with COVID-19 in order to be an idea of collecting data for treatment with anti-cancer drugs that cause lymphopenia."],"journal":"Med Oncol","authors":["Tanriverdi, Ozgur"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333196","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s12032-020-01376-8","keywords":["covid- 19","cancer patients","lymphopenia","mortality"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Temozolomide"],"_version_":1665071049724657664,"score":43.35841},{"pmid":32212881,"pmcid":"PMC7117596","title":"Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.","text":["Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.","Immunotherapy","Bersanelli, Melissa","32212881"],"journal":"Immunotherapy","authors":["Bersanelli, Melissa"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32212881","week":"202013|Mar 23 - Mar 29","doi":"10.2217/imt-2020-0067","keywords":["anti-ctla-4","covid-19","sars-cov-2","anti-pd-1","anti-pd-l1","cancer patients","immune checkpoint inhibitors","immunotherapy","tocilizumab","viral infection"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664638838302048258,"score":42.122223},{"pmid":32326986,"title":"Impact of COVID-19 on Mental Healthcare of Older Adults: Insights from Lebanon (Middle East).","text":["Impact of COVID-19 on Mental Healthcare of Older Adults: Insights from Lebanon (Middle East).","Int Psychogeriatr","Khoury, Rita","Karam, Georges","32326986"],"journal":"Int Psychogeriatr","authors":["Khoury, Rita","Karam, Georges"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32326986","week":"202017|Apr 20 - Apr 26","doi":"10.1017/S104161022000068X","source":"PubMed","weight":0,"locations":["Lebanon"],"countries":["Lebanon"],"countries_codes":["LBN|Lebanon"],"_version_":1664996914964201474,"score":41.65474}]}